Benchling IPO

Benchling operates a cloud-based platform specifically designed for biotechnology research and development, serving as the backbone for R&D workflows at pharmaceutical, biotech, and academic institutions. The platform integrates laboratory information management, electronic lab notebooks, molecular biology tools, and workflow automation into a unified system that enables scientists to design experiments, track samples, manage protocols, and analyze results seamlessly.

The company has established itself as a critical infrastructure provider for the life sciences industry, with customers including major pharmaceutical companies, biotech unicorns, and leading academic research institutions. Benchling's platform supports everything from basic research to clinical development, making it particularly valuable as organizations scale their research operations and need to maintain regulatory compliance while accelerating discovery timelines.